drugset

drugset / Trial / NCT00674856

A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function

NCT00674856 ↗

Phase 1 Completed 32 enrolled NicOx

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To study the pharmacokinetics and safety of naproxcinod in patients with impaired renal function

Timeline

Start: 2008-05
Primary completion: 2008-09
Completion: 2008-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	naproxcinod	Other / unclassified	750 mg	—

Indications